{"DataElement":{"publicId":"6479328","version":"1","preferredName":"Merkel Cell Cancer AJCC Edition 8 Pathologic Group Stage","preferredDefinition":"Pathologic stage group based on the combination of T, N, and M categories and relevant prognostic factors for merkel cell carcinoma, using AJCC Ed. 8 criteria.","longName":"MCC_AJC8_PTH_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6477695","version":"1","preferredName":"Merkel Cell Neoplasm Pathologic Stage Grouping","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6477683v1.0:2230144v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6477683","version":"1","preferredName":"Merkel Cell Neoplasm","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12592:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell","conceptCode":"C12592","definition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E3EF07-8EE9-4141-E053-F662850A90EE","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"77DF1D11-49DD-583C-E053-F662850AAF73","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-10-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6479297","version":"1","preferredName":"Merkel Cell Carcinoma American Joint Committee on Cancer Edition 8 Pathologic Group Stage","preferredDefinition":"A term that refers to the pathologic staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6479297v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Pathologic Stage IV Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479299","version":"1","preferredName":"Pathologic Stage IV Merkel Cell Carcinoma AJCC v8","longName":"6479299","preferredDefinition":"Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis microscopically confirmed. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136889","definition":"Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis microscopically confirmed. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F65F-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F678-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479301","version":"1","preferredName":"Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8","longName":"6479301","preferredDefinition":"Stage IIIB includes: T1-4, N1b-3, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136888","definition":"Stage IIIB includes: T1-4, N1b-3, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F685-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F69E-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479303","version":"1","preferredName":"Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8","longName":"6479303","preferredDefinition":"Stage IIIA includes: (T1-4, N1a(sn) or N1a, M0); (T0, N1b, M0). T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1a(sn): Clinically occult regional lymph node metastasis identified only by sentinel lymph node biopsy. N1a: Clinically occult regional lymph node metastasis following lymph node dissection. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136887","definition":"Stage IIIA includes: (T1-4, N1a(sn) or N1a, M0); (T0, N1b, M0). T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1a(sn): Clinically occult regional lymph node metastasis identified only by sentinel lymph node biopsy. N1a: Clinically occult regional lymph node metastasis following lymph node dissection. N1b: Clinically and/or radiologically detected regional lymph node metastasis, microscopically confirmed. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F6AB-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F6C4-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479305","version":"1","preferredName":"Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8","longName":"6479305","preferredDefinition":"Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIB Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136885","definition":"Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F6D1-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F6EA-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479307","version":"1","preferredName":"Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8","longName":"6479307","preferredDefinition":"Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage IIA Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136884","definition":"Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F6F7-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F710-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"I","valueDescription":"Pathologic Stage I Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479309","version":"1","preferredName":"Pathologic Stage I Merkel Cell Carcinoma AJCC v8","longName":"6479309","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136882","definition":"Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F71D-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F736-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"0","valueDescription":"Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8","ValueMeaning":{"publicId":"6479311","version":"1","preferredName":"Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8","longName":"6479311","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic Stage 0 Cutaneous Merkel Cell Carcinoma AJCC v8","conceptCode":"C136881","definition":"Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on pathologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F743-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F6CD24-F75C-0EA5-E053-F662850A752C","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6479296","version":"1","preferredName":"Merkel Cell Carcinoma by AJCC v8 Pathologic Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the pathologic staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C136880:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Merkel Cell Carcinoma by AJCC v8 Pathologic Stage","conceptCode":"C136880","definition":"A term that refers to the pathologic staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F6CD24-F632-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F6CD24-F643-0EA5-E053-F662850A752C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6477698","version":"1","longName":"Merkel Cell","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic disease stage","type":"Preferred Question Text","description":"Pathologic disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F77ACA-6F79-0E59-E053-F662850AC43C","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}